Maarten T. Bastiaens
Leiden University Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maarten T. Bastiaens.
American Journal of Human Genetics | 2001
Maarten T. Bastiaens; Jeannet ter Huurne; Christine J. Kielich; Nelleke A. Gruis; Rudi G. J. Westendorp; Bert Jan Vermeer; Jan Nico Bouwes Bavinck
Melanocortin-1 receptor (MC1R) gene variants are associated with fair skin and red hair and, independently of these, with cutaneous malignant melanoma. The association of MC1R gene variants with nonmelanoma skin cancer is largely unknown. A total of 838 subjects were included in the present study: 453 patients with nonmelanoma skin cancer and 385 subjects with no skin cancer. The coding sequence of the human MC1R gene was tested using single-stranded conformation polymorphism analysis followed by sequencing of unknown variants. Risk of skin cancer dependent on the various MC1R gene variants was estimated using the exposure odds ratio. We investigated whether subjects with MC1R variant alleles were at increased risk of developing nonmelanoma skin cancer and, if so, whether this increased risk was mediated by fair skin and red hair. A total of 27 MC1R gene variants were found. The number of carriers of one, two, or three MC1R gene variants was 379 (45.2%), 208 (24.8%), and 7 (0.9%), respectively. A strong association between MC1R gene variants and fair skin and red hair was established, especially the variants Arg151Cys and Arg160Trp (P < .0001). Carriers of two variant alleles were at increased risk for developing cutaneous squamous cell carcinoma (odds ratio 3.77; 95% confidence interval [CI] 2.11-6.78), nodular basal cell carcinoma (odds ratio 2.26; 95% CI 1.45-3.52), and superficial multifocal basal cell carcinoma (odds ratio 3.43; 95% CI 1.92-6.15), compared with carriers of two wild-type alleles. Carriers of one variant allele had half the risk. The highest relative risks of nonmelanoma skin cancer were found in carriers of the Asp84Glu, His260Pro, and Asp294His variant alleles, and the risk was only slightly lower for carriers of the Val60Leu, Val92Met, Arg142His, Arg151Cys, and Arg160Trp variant alleles. When subjects were stratified by skin type and hair color, analysis showed that these factors did not materially change the relative risks. These findings indicate that MC1R gene variants are important independent risk factors for nonmelanoma skin cancer.
Journal of Clinical Oncology | 2001
Sofie A.E. De Hertog; Christianne A.H. Wensveen; Maarten T. Bastiaens; Christine J. Kielich; Marjo J.P. Berkhout; Rudi G. J. Westendorp; Bert Jan Vermeer; Jan Nico Bouwes Bavinck
PURPOSE Tobacco smoking is a risk factor for several cancers. The risk of cutaneous malignancies related to smoking, however, is relatively unknown. We investigated the possible association between smoking and skin cancer. PATIENTS AND METHODS A hospital-based case-control study was performed that included 161 patients with squamous cell carcinoma, 301 with nodular basal cell carcinoma, 153 with superficial multifocal basal cell carcinoma, 125 with malignant melanoma, and 386 controls. Information on smoking history was collected in personal interviews. Relative risks were estimated using exposure odds ratios from cross-tabulation and logistic regression. RESULTS An association between smoking and squamous cell carcinoma of the skin was found (relative risk, 2.3; 95% confidence interval, 1.5 to 3.6; P: = .0001), with a higher risk for current smokers (relative risk, 3.3; 95% confidence interval, 1.9 to 5.5) than for former smokers (relative risk, 1.9; 95% confidence interval, 1.2 to 3.0). After adjustment for age, sex, and sun exposure, the relative risk of squamous cell carcinoma was 2.0 (95% confidence interval, 1.2 to 3.2; P: = .008). There was a dose-response relationship with number of cigarettes and pipes smoked. No significant association was found between smoking and nodular basal cell carcinoma, superficial multifocal basal cell carcinoma, or malignant melanoma. CONCLUSION Tobacco smoking is an independent risk factor for cutaneous squamous cell carcinoma.
Journal of Investigative Dermatology | 2001
C. Kennedy; Jeanet ter Huurne; Marjo J.P. Berkhout; Nelleke A. Gruis; Maarten T. Bastiaens; Wilma Bergman; Rein Willemze; Jan Nico Bouwes Bavinck
Journal of Investigative Dermatology | 1998
Maarten T. Bastiaens; Juliette J. Hoefnagel; Bert Jan Vermeer; Jan Nico Bouwes Bavinck; Jan A. Bruijn; Rudi G. J. Westendorp
Human Molecular Genetics | 2001
Maarten T. Bastiaens; Jeanette ter Huurne; Nelleke A. Gruis; Wilma Bergman; Rudi G. J. Westendorp; B.J. Vermeer; Jan-Nico Bouwes Bavinck
Journal of Investigative Dermatology | 2004
Elisabeth de Vries; M Louwman; Maarten T. Bastiaens; Frank R. de Gruijl; Jan Willem J. Coebergh
Journal of Investigative Dermatology | 2003
C. Kennedy; Maarten T. Bastiaens; Rein Willemze; Jan Nico Bouwes Bavinck; Chris Bajdik; Rudi G. J. Westendorp
Pigment Cell Research | 2004
Maarten T. Bastiaens; Juliette J. Hoefnagel; Rudi G. J. Westendorp; B.J. Vermeer; Jan Nico Bouwes Bavinck
Pigment Cell Research | 1999
Maarten T. Bastiaens; Rudi G. J. Westendorp; Bert Jan Vermeer; Jan Nico Bouwes Bavinck
Archives of Dermatology | 2000
Jan Nico Bouwes Bavinck; Maarten T. Bastiaens; Marion E. Marugg; Roeland C. Y. Beckers; Rudi G. J. Westendorp; Bert Jan Vermeer; Frans H.J. Claas